Coxsackievirus A21 antiserum [V-024-501-563] (ATCC® VR-1029AS/MK)

Strain: Kuykendall  /  Product Format: freeze-dried 0.5 mL

Deposited As Coxsackievirus A21
Agent Coxsackievirus A21 antiserum [V-024-501-563]
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried 0.5 mL
Storage Conditions 4°C
Comments
Immunogen: Picornavirus, Enterovirus, Coxsackievirus A21, and Strain Kuykendall
Source of antibody: Rhesus monkey
Propagated in: human amnion cells in tissue culture
Adjuvant: 1 part Arlacel A plus 9 parts Bayol F with equal amounts of undiluted suspension of virus
Name of Depositor NIH/NIAID, University of Kanasas Medical Center
Source Monkey immune serum prepared against Coxsackievirus A 21 strain Kuykendall
References

Kamitsuka PS, et al. Preparation and standardization of Coxsackievirus reference antisera. I. For twenty-four group A viruses. Am. J. Epidemiol. 81: 283-306, 1965. PubMed: 14294414

Melnick JL, Ledinko N. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J. Exp. Med. 92: 463-482, 1950. PubMed: 14778925